ILMN (STOCKS)
Illumina Inc
$116.297500
+1.857500 (+1.62%)
Prev close: $114.440000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Jacob Thaysen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $17,848.57M
- Employees
- 8,970
- P/E (TTM)
- 21.44
- P/B (TTM)
- 6.56
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
6
Buy
10
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.35 | $1.25 | +0.0956 | +7.62% |
|
Sep 2025 (Q3)
|
$1.34 | $1.19 | +0.1491 | +12.52% |
|
Jun 2025 (Q2)
|
$1.19 | $1.03 | +0.1577 | +15.28% |
|
Mar 2025 (Q1)
|
$0.97 | $0.96 | +0.0127 | +1.33% |
Financial Statements
| Revenues | $4.34B |
| Benefits Costs and Expenses | $3.26B |
| Cost Of Revenue | $1.47B |
| Costs And Expenses | $3.26B |
| Gross Profit | $2.87B |
| Nonoperating Income/Loss | $279.00M |
| Operating Expenses | $2.06B |
| Selling, General, and Administrative Expenses | $1.09B |
| Research and Development | $967.00M |
| Other Operating Expenses | $10.00M |
| Operating Income/Loss | $807.00M |
| Income/Loss From Continuing Operations After Tax | $850.00M |
| Income/Loss From Continuing Operations Before Tax | $1.09B |
| Income Tax Expense/Benefit | $236.00M |
| Income Tax Expense/Benefit, Current | $117.00M |
| Income Tax Expense/Benefit, Deferred | $119.00M |
| Net Income/Loss | $850.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $850.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $850.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $5.47 |
| Diluted Earnings Per Share | $5.45 |
| Basic Average Shares | 155,000,000 |
| Diluted Average Shares | 156,000,000 |
| Assets | $6.64B |
| Current Assets | $3.29B |
| Inventory | $564.00M |
| Other Current Assets | $2.73B |
| Noncurrent Assets | $3.36B |
| Fixed Assets | $759.00M |
| Intangible Assets | $210.00M |
| Other Non-current Assets | $2.39B |
| Liabilities | $3.92B |
| Current Liabilities | $1.59B |
| Accounts Payable | $240.00M |
| Wages | $249.00M |
| Other Current Liabilities | $1.10B |
| Noncurrent Liabilities | $2.34B |
| Equity | $2.72B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.72B |
| Liabilities And Equity | $6.64B |
| Net Cash Flow From Operating Activities | $1.08B |
| Net Cash Flow From Operating Activities, Continuing | $1.08B |
| Net Cash Flow From Investing Activities | -$55.00M |
| Net Cash Flow From Investing Activities, Continuing | -$55.00M |
| Net Cash Flow From Financing Activities | -$744.00M |
| Net Cash Flow From Financing Activities, Continuing | -$744.00M |
| Exchange Gains/Losses | $11.00M |
| Net Cash Flow | $291.00M |
| Net Cash Flow, Continuing | $280.00M |
| Comprehensive Income/Loss | $818.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $818.00M |
| Other Comprehensive Income/Loss | $818.00M |